RA Capital Management, L.P. 13D/13G Filings for Dianthus Therapeutics, Inc. (DNTH)

RA Capital Management, L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
6:32 pm
Sale		 2024-12-31 13G Dianthus Therapeutics, Inc.
DNTH		 RA Capital Management, L.P. 2,866,733
9.400%		 -128,290decrease
(-4.28%)		 Filing
2024-02-01
6:22 pm
Purchase		 2024-01-22 13G Dianthus Therapeutics, Inc.
DNTH		 RA Capital Management, L.P. 2,995,023
9.990%		 2,995,023increase
(New Position)		 Filing